This is the list of companies and organisations who
will be attending the 6th Annual North America Forum for Investing & Partnering
in Biotech, Boston 2007.
| 3i Investments |
| Acambis |
| Accelsiors Group |
| Acretia |
| Advent International |
| AerovectRx Corporation |
| Aisling Capital |
| Alfacell Corporation |
| Alnylam Pharmaceuticals, Inc. |
| Altius Strategy Group |
| American Stock Exchange |
| Apeiron Partners |
| APS International |
| AstraZeneca R & D Boston |
| Attogen Biomedical Research |
| Banc of America Securities LLC |
| BankInvest |
| Beth Israel Deaconess Medical Center |
| Bexion Pharmaceuticals |
| Bio One Capital |
| BioConnect |
| Biomira |
| BioMS Medical Corp. |
| BioNet Holding GmbH |
| Bionomics |
| BioSante Pharmaceuticals |
| BioTeam Paris Region |
| Bioveda Capital |
| Boston Life Sciences |
| Cambria Biosciences |
| Cambridge Associates |
| Cantor Fitzgerald |
| Capital Royalty |
| CBT Advisors |
| Cellerix |
| Comerica Bank |
| Consulate General of Canada in Boston |
| Cornell Capital Partners |
| Deutsche Bank |
| Edison Investment Research |
| Edwards Angell Palmer & Dodge |
| EGS Healthcare |
| Endo Pharmaceuticals Inc. |
| Epidauros Biotechnologie AG |
| Everest Pharm |
| F. Hoffmann-La Roche |
| Flagship Ventures |
| Genzyme Corporation |
| GGA Software |
| Global Markets Capital Group, LLC |
| Harvard University, Office of Technology Development |
| Health Advances |
| HealthCare Ventures |
| Hercules Technology Growth Capital |
| Hub Management Investment Group |
| InForsyth |
| Inotek Pharmaceuticals Corporation |
| Invest Quebec |
| Johnson & Johnson |
| Joseph Stevens & Co. |
| Katan Associates |
| KBL Healthcare Ventures |
| Life Science Advisors |
| Louisiana Fund I |
| MDJ Consulting |
| Medical Device Works ebvba |
| Merrill Lynch |
| Mersana Therapeutics |
| Michael J. Fox Foundation For Parkinson's Research |
| Millennium Pharmaceuticals |
| Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
| MIT Sloan School of Management |
| MPM Capital LP |
| Neomed Management |
| Neuro-Hitech, Inc. |
| Neurologix, Inc. |
| Nextech Venture |
| NGN Capital |
| Novartis Institutes for BioMedical Research, Inc |
| Novartis Pharmaceuticals |
| Novosom AG (DE) |
| Nuevolution |
| Nventa Biopharmaceuticals |
| Oakes, Lyman & Co |
| Oppenheimer & Company |
| Orexo AB |
| Oxford Bioscience Partners |
| Oxford Immunotec |
| Paramount BioSciences |
| Partners HealthCare |
| Pevion Biotech |
| PharmaVentures |
| Radcliffe Consulting Inc |
| RCT BioVentures |
| Rockport Venture Partners |
| RogersIPGroup |
| Royalmount Pharma |
| Semaphore |
| SEPA Capital |
| Serono Research Institute |
| Sherris Pharma Partners |
| SMC |
| Stem Cell Therapeutics |
| SuperGen, Inc. |
| The Pentad Group |
| Thermo Fisher Scientific |
| Thiakis Limited |
| Translational Therapeutics |
| Transport Pharmaceuticals, Inc. |
| TSG Partners |
| Two River Group Holding |
| Vakzine Projekt Management |
| VioQuest Pharmaceuticals |
| Walsh Strategy Group |
| Warburg Pincus |